Cepheid to Offer HIV, HCV Testing Under Amended License Deal with Applera | GenomeWeb

Cepheid to Offer HIV, HCV Testing Under Amended License Deal with Applera

Jun 29, 2006

NEW YORK, June 29 (GenomeWeb News) - Cepheid and Applera have amended a license agreement between the companies to allow Cepheid to sell two of its real-time thermal cyclers to detect, characterize, and monitor HIV and hepatitis C infections, the companies said today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Laureates Warn Against Hard Brexit

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

For All

Vox reports on inequities in genetic research and efforts to address them.

Lawrence Krauss to Retire Following Sexual Misconduct Allegations

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

This Week in PNAS

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.